ELOXX PHARMACEUTICALS INC's ticker is ELOX and the CUSIP is 29014R103. A total of 45 filers reported holding ELOXX PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $137,000 | -36.0% | 807,678 | +0.7% | 0.00% | – |
| Q2 2022 | $214,000 | -52.2% | 802,413 | +0.3% | 0.00% | – |
| Q1 2022 | $448,000 | -19.7% | 800,333 | +0.3% | 0.00% | – |
| Q4 2021 | $558,000 | -55.7% | 798,058 | +3.3% | 0.00% | – |
| Q3 2021 | $1,259,000 | +20.0% | 772,836 | +46.6% | 0.00% | – |
| Q2 2021 | $1,049,000 | -28.8% | 527,307 | +18.8% | 0.00% | – |
| Q1 2021 | $1,473,000 | -11.8% | 443,810 | +5.7% | 0.00% | – |
| Q4 2020 | $1,670,000 | +52.5% | 419,745 | +0.8% | 0.00% | – |
| Q3 2020 | $1,095,000 | -8.9% | 416,499 | +4.9% | 0.00% | – |
| Q2 2020 | $1,202,000 | +59.2% | 396,993 | +3.0% | 0.00% | – |
| Q1 2020 | $755,000 | -85.2% | 385,261 | -44.4% | 0.00% | -100.0% |
| Q4 2019 | $5,094,000 | +284.2% | 692,304 | +136.0% | 0.00% | – |
| Q3 2019 | $1,326,000 | -51.0% | 293,376 | +8.1% | 0.00% | -100.0% |
| Q2 2019 | $2,704,000 | -6.1% | 271,298 | +10.1% | 0.00% | 0.0% |
| Q1 2019 | $2,879,000 | -49.6% | 246,520 | -48.2% | 0.00% | 0.0% |
| Q4 2018 | $5,716,000 | +55.1% | 475,972 | +120.0% | 0.00% | 0.0% |
| Q3 2018 | $3,686,000 | +6.5% | 216,352 | +6.7% | 0.00% | 0.0% |
| Q2 2018 | $3,460,000 | – | 202,700 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|